← All trials
NCT05434897
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2022
- Primary completion
- Jul 31, 2023
- Completion date
- Nov 30, 2023
- First posted
- Jun 28, 2022
- Last posted
- Jul 6, 2022
- Enrollment
- 30
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Ark Biosciences Inc.Lead sponsor
- Ark Biosciences Inc.Collaborator
- University of California, San FranciscoStudy chair
- InnovadermStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.